These Cosigners would work with Olivia anywhere
1 unread notifications
Olivia H. Scharfman Biosecurity & Biotechnology @IFP. Formerly: Co-founder @ LincSwitch Tx, Principal @ SALT Fund, Biophysics @Yale, Chairman @SEDSusa, @XPRIZE.
Olivia H. Scharfman Biosecurity & Biotechnology @IFP. Formerly: Co-founder @ LincSwitch Tx, Principal @ SALT Fund, Biophysics @Yale, Chairman @SEDSusa, @XPRIZE.
Career
Olivia H. Scharfman studied at Yale University (B.S. in Molecular Biophysics and Biochemistry).
Biotechnology Fellow at Institute for Progress from 2026-05 to PresentWorks on biosecurity and biotechnology policy, including preparation for risks from increasingly capable AI.
Talent Investor, Biosecurity (contract) at BlueDot Impact from 2026-05 to PresentDevelops biosecurity strategy and helps researchers and builders work on reducing catastrophic biological risks.IBiosecurity and Biodefense Consultant at Independent from 2025-05 to 2026-05Advised on biodefense strategy and policy.
LTCo-founder at LincSwitch Therapeutics from 2023-11 to 2025-05Co-founded a biotechnology company focused on long non-coding RNA therapeutics.
SFPrincipal at SALT Fund from 2022-07 to 2024-05Worked in venture investing before co-founding LincSwitch Therapeutics.
YSResearcher at Yale School of Medicine from 2021 to 2022Studied molecular mechanisms of aging in Morgan Levine’s Aging in Living Systems laboratory.
Development and Research Analyst Intern at XPRIZE from 2017-02 to 2017-05Supported research and development work at XPRIZE.DRBiophysics and Electrical Engineering Intern at DEKA Research & Development from 2016-05 to 2016-08Worked on biophysics and electrical engineering research and development.
Cosigns Received